Core Cap Advisors, LLC Arcturus Therapeutics Holdings Inc. Transaction History
Core Cap Advisors, LLC
- $2.12 Billion
- Q4 2024
A detailed history of Core Cap Advisors, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 75 shares of ARCT stock, worth $1,353. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 100
25.0%
Holding current value
$1,353
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ARCT
# of Institutions
172Shares Held
25.1MCall Options Held
166KPut Options Held
135K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$84.7 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$47.8 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$37.3 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$37.3 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$34.9 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $480M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...